Abstract
Pulmonary transplant is, nowadays, a fundamental part in the treatment of pulmonary terminal diseases, constituting an efficient therapeutic modality for patients with incapacity lung disease, progressive and in the final stage, being the more important ones: obstructive chronic lung disease, emphysema caused by deficiency of Alpha 1 antitrypsin, pulmonary hypertension, pulmonary and cyst…